Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb … Eisai logo and Biogen logo (PRNewsfoto/Eisai Co., Ltd.) News provided by. Eisai Inc. Nov 25, 2025, 07 … By AJDesign77|2025-11-25T13:22:10+00:00November 25th, 2025|Uncategorized|0 Comments Share This Story, Choose Your Platform! FacebookXRedditLinkedInTumblrPinterestVkEmail About the Author: AJDesign77 Related Posts New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies New CAR T-Cell Therapy Earns FDA Breakthrough Status in T-Cell Malignancies House Democrats want ICE, CBP uniforms to feature identification tech – FedScoop House Democrats want ICE, CBP uniforms to feature identification tech – FedScoop This Week at FDA: HHS ends aborted fetal tissue research, PreCheck pilot update, and more | RAPS This Week at FDA: HHS ends aborted fetal tissue research, PreCheck pilot update, and more | RAPS DEA Administrator Terrance Cole on the Capture of Ryan Wedding DEA Administrator Terrance Cole on the Capture of Ryan Wedding FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease